Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ACADIA Pharmaceuticals Inc

+ Add to Watchlist

ACAD:US

32.0400 USD 0.5500 1.69%

As of 20:10:00 ET on 04/01/2015.

Company Profile for ACADIA Pharmaceuticals Inc (ACAD)

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Contact Information

ACADIA Pharmaceuticals Inc

11085 Torreyana Road
Suite 100
San Diego, CA 92121
United States
Phone: 1-858-558-2871
Fax: 1-858-558-2872

Key Executives for ACADIA Pharmaceuticals Inc (ACAD)

Stephen R Davis "Steve"Interim CEO/Exec VP/CFOTerrence O MooreExec VP/Chief Commercial Officer
Roger M MillsExec VP:Dev/Chief Medical OfcrGlenn F BaityVP/Secy/General Counsel
Lisa BarthelemyDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil